Results 11 to 20 of about 171,828 (231)

Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions

open access: yesTherapeutics and Clinical Risk Management, 2011
Vani JA Konda1, Kunal Dalal21Section of Gastroenterology, Department of Medicine, 2Department of Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USAAbstract: Esophageal adenocarcinoma and its precursor, Barrett's ...
Konda VJA, Dalal K
doaj   +1 more source

Educational Case: Barrett Esophagus [PDF]

open access: yesAcademic Pathology, 2019
The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for teaching pathology.
Mackinzie McDaniel BS   +1 more
doaj   +2 more sources

Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer. [PDF]

open access: yesAnn Surg, 2019
OBJECTIVE: To investigate differences in methylation between patients with nondysplastic Barrett esophagus who progress to invasive adenocarcinoma and those who do not.BACKGROUND: Identifying patients with nondysplastic Barrett esophagus who progress to ...
Dilworth MP   +12 more
europepmc   +2 more sources

Dysplasia in Barrett esophagus [PDF]

open access: yes, 2004
BACKGROUND Dysplasia in Barrett esophagus is a premalignant condition that is associated with an increased risk of developing esophageal adenocarcinoma.
Kent A. Griffith   +17 more
core   +1 more source

Management of Barrett’s Esophagus: Practice-Oriented Answers to Clinical Questions [PDF]

open access: yes, 2023
Barrett’s esophagus is the most important complication of gastro-esophageal reflux disease and the only known precursor of esophageal adenocarcinoma. The diagnosis and treatment of Barrett’s esophagus are clinically challenging as it requires
Veronica Iascone   +9 more
core   +1 more source

Origin of adenocarcinoma in Barrett's esophagus: P53 and Ki67 expression and histopathologic background Origem do adenocarcinoma no esôfago de Barrett: bases histopathológicas e expressão dos genes p53 e Ki67

open access: yesClinics, 2005
Barrett's esophagus is the substitution of squamous epithelium of the distal esophagus by columnar epithelium. Intestinal metaplasia in Barrett's esophagus is considered to be the main risk factor for the development of adenocarcinoma.
Sergio Szachnowicz   +5 more
doaj   +1 more source

Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. [PDF]

open access: yesPLoS Genetics, 2011
Although a combination of genomic and epigenetic alterations are implicated in the multistep transformation of normal squamous esophageal epithelium to Barrett esophagus, dysplasia, and adenocarcinoma, the combinatorial effect of these changes is unknown.
Hector Alvarez   +23 more
doaj   +1 more source

Uncommon cases of foreign bodies in the esophagus--duplex coins [PDF]

open access: yes, 1970
Two cases of multiple foreign bodies, i. e., duplex coins in the esophagus are reported. These foreign bodies were removed by peroral esophagoscopy successfully.
Tasaka, Seido, Oguri, Yoshio
core   +1 more source

Barrett esophagus frequency and predictors of dysplasia or cancer in Barrett esophagus

open access: yes, 2022
OBJECTIVE: Identificating factors associated with an increased risk for dysplasia and cancer development among patients with Barrett esophagus would aid better patient care and improve risk stratification approaches.
Çiçek, B.   +2 more
core   +1 more source

Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease Prevalência do esôfago de Barrett em indivíduos sem sintomas típicos da doença por refluxo gastroesofágico

open access: yesArquivos de Gastroenterologia, 2008
BACKGROUND: Barrett’s esophagus, the major risk factor for esophageal adenocarcinoma, is detected in approximately 10%-14% of individuals submitted to upper endoscopy for the assessment of gastroesophageal reflux disease related symptoms.
Mauro Carneiro de Freitas   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy